Company intelligence / Profile preview

Supira Medical

Campbell, California, United Statessupiramedical.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Supira Medical is developing the Supira System, a next-generation percutaneous ventricular assist device designed to provide temporary mechanical circulatory support for high-risk PCI and cardiogenic shock patients. The company has received FDA Breakthrough Device Designation and completed enrollment in an early feasibility study in the US. Over 70 patients have been treated in South American trials. The company recently raised $120 million to fund pivotal US studies supporting premarket approval applications.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically, percutaneous ventricular assist device)
Industry: Therapeutic Medical Devices

Partnerships

Unorthodox VenturesCormorant Asset ManagementThe Capital PartnershipNovo HoldingsQatar Investment Authority

Beyond the preview

Go deeper on Supira Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supira Medical.

Explore the full profile